Malaysian Genomics Resource (0155) — Cash Flow Reinvestment Rate
Malaysian Genomics Resource (0155) has a Cash Flow Reinvestment Rate of 0.08x as of June 2026, reinvesting RM78.00K (capex RM78.00K ) from operating cash flow of RM1.01 Million. See 0155 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Malaysian Genomics Resource Cash Flow Reinvestment Rate (2015–2026)
Historical reinvestment intensity for Malaysian Genomics Resource across 6 annual periods. For the full cash flow conversion analysis, see how efficiently does Malaysian Genomics Resource generate cash.
Annual Cash Flow Reinvestment Rate for Malaysian Genomics Resource (2015–2026)
Year-by-year capital reinvestment analysis for Malaysian Genomics Resource. See Malaysian Genomics Resource free cash flow to debt ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (MYR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2026 | 0.06x | RM71.64K | RM1.10 Million | RM71.64K | ▼ -99.9% |
| 2022 | 66.19x | RM3.77 Million | RM56.92K | RM1.33 Million | ▲ +2350.0% |
| 2020 | 2.70x | RM31.52 Million | RM11.67 Million | RM351.18K | ▼ -15.3% |
| 2017 | 3.19x | RM11.72 Million | RM3.67 Million | RM143.49K | ▲ +4571.4% |
| 2016 | 0.07x | RM251.52K | RM3.68 Million | RM181.42K | ▼ -91.5% |
| 2015 | 0.80x | RM318.34K | RM395.83K | RM318.34K | — |